Rare diseases
Investigational molecules
Locations
Avenida De Manuel Siurot S/n, 41013 Sevilla, Spain
Virgen del Rocío University Hospital in Sevilla, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Breast cancer, Plasma cell myeloma, Migraine, and other specialisations. This site conducts important research.
At Virgen del Rocío University Hospital, the clinical trial portfolio is centered on Psychiatry and Psychology, with a strong focus on Mental Disorders. The research is primarily aimed at understanding and improving care for people living with schizophrenia, including studies that explore whether new approaches can support cognitive function and daily mental performance.
This work reflects a clear commitment to better diagnostics and treatment effectiveness in severe psychiatric illness, supported by a large investigator network at the site.
Clinical trials currently enrolling participants at this site.
Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
SpainPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
SpainEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
SpainStudy of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
SpainPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
SpainLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
SpainA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
SpainPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
SpainA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
SpainA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
SpainStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
SpainPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
